SCHEMBL8322745

SCHEMBL8322745

Nc1nc(Nc2cc(F)c(Oc3ccnc4[nH]ccc34)c(F)c2)cc(-c2ccncc2)n1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 19/20 0.82
CYP3A4 P08684 3/20 0.82
ROCK1 Q13464 2/20 0.51
CDC7 O00311 1/20 0.51
CHEK1 O14757 1/20 0.51
AURKA O14965 1/20 0.51
PDPK1 O15530 1/20 0.51
DAPK3 O43293 1/20 0.51
DYRK3 O43781 1/20 0.51
CACNA1F O60840 1/20 0.51
RAF1 P04049 1/20 0.51
ERBB2 P04626 1/20 0.51
NTRK1 P04629 1/20 0.51
INSR P06213 1/20 0.51
CDK1 P06493 1/20 0.51
FES P07332 1/20 0.51
CSF1R P07333 1/20 0.51
LYN P07948 1/20 0.51
MET P08581 1/20 0.51
ROS1 P08922 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8322600 0.93 ROCK2 (0.70) ROCK2CYP3A4ROCK1CDC7CHEK1
SCHEMBL2880069 0.90 ROCK2 (1.00) ROCK2CYP3A4ROCK1MET
SCHEMBL13295217 0.85 ROCK2 (0.80) ROCK2CYP3A4ROCK1CDC7CHEK1
SCHEMBL2881172 0.85 ROCK2 (0.80) ROCK2CYP3A4ROCK1CDC7CHEK1
SCHEMBL2879936 0.84 ROCK2 (0.71) ROCK2CYP3A4ROCK1MET
SCHEMBL2882221 0.83 ROCK2 (0.86) ROCK2CYP3A4MET
SCHEMBL8271611 0.80 ROCK2 (0.71) ROCK2CYP3A4ROCK1
SCHEMBL8333413 0.79 ROCK2 (0.80) ROCK2CYP3A4MET
SCHEMBL2881732 0.77 ROCK2 (0.53) ROCK2CYP3A4MET
SCHEMBL13295330 0.77 ROCK2 (0.81) ROCK2CYP3A4MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737153-B2 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-15 US disclosed
US-7737153-B2 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-15 US disclosed
WO-2004039796-A1 HETEROARYLOXY-SUBSTITUTED PHENYLAMINOPYRIMIDINES AS RHO-KINASE INHIBITORS BAYER HEALTHCARE AG (DE) 2004-05-13 WO disclosed